Literature DB >> 6392104

Serological diagnosis of erythema migrans disease and related disorders.

B Wilske, G Schierz, V Preac-Mursic, K Weber, H W Pfister, K Einhäupl.   

Abstract

An indirect immunofluorescence technique for the determination of antibodies against ixodid tick spirochetes is described. Differences in the reactivity between Ixodes ricinus spirochete and Ixodes dammini spirochete antigens were not observed. Cross-reacting antibodies against Treponema pallidum and Treponema phagedenis can be eliminated by quantitative absorption with T. phagedenis. Cross-reactions with leptospira were not observed by immunofluorescence. In the IgM test, false negative reactions caused by high-titered specific IgG antibodies or false positive reactions caused by rheumatoid factor occur. This can be avoided by testing the IgM fraction (19S-IgM-test) or using sera previously treated with anti-IgG serum. Significantly elevated antibody titers against ixodid tick spirochetes were observed in 45% of 44 cases with erythema migrans disease, in 72% of 29 cases of lymphocytic meningoradiculitis, in all of nine patients with acrodermatitis chronica atrophicans and in all of four investigated patients with lymphocytoma (lymphadenosis benigna cutis).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6392104     DOI: 10.1007/BF01651147

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  18 in total

1.  [Meningopolyneuritis (Garin-Bujadoux, Bannwarth). Clinical aspects and laboratory findings].

Authors:  W Kristoferitsch; G Spiel; P Wessely
Journal:  Nervenarzt       Date:  1983-12       Impact factor: 1.214

2.  Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease.

Authors:  H Russell; J S Sampson; G P Schmid; H W Wilkinson; B Plikaytis
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

3.  The spirochetal etiology of Lyme disease.

Authors:  A C Steere; R L Grodzicki; A N Kornblatt; J E Craft; A G Barbour; W Burgdorfer; G P Schmid; E Johnson; S E Malawista
Journal:  N Engl J Med       Date:  1983-03-31       Impact factor: 91.245

4.  Indirect immunofluorescence test for detection of IgM antibodies to cytomegalovirus.

Authors:  A C Hekker; B Brand-Saathof; J Vis; R C Meijers
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

5.  [Erythema migrans disease. A contribution to its clinical features and relation to Lyme disease].

Authors:  K Weber; A Puzik; T Becker
Journal:  Dtsch Med Wochenschr       Date:  1983-08-05       Impact factor: 0.628

6.  [Lyme arthritis (erythema migrans arthritis)].

Authors:  W Müller
Journal:  Schweiz Med Wochenschr       Date:  1984-02-25

7.  [Spirochete etiology of erythema chronicum migrans disease].

Authors:  R Ackermann; J Kabatzki; H P Boisten; A C Steere; R L Grodzicki; S Hartung; U Runne
Journal:  Dtsch Med Wochenschr       Date:  1984-01-20       Impact factor: 0.628

8.  [Erythema chronicum migrans with arthritis (author's transl)].

Authors:  R Ackermann; U Runne; W Klenk; C Dienst
Journal:  Dtsch Med Wochenschr       Date:  1980-12-19       Impact factor: 0.628

9.  [Chronic erythema migrans and tick-transmitted meningopolyneuritis (Garin-Bujadoux-Bannwarth): Borrelia infections?].

Authors:  R Ackermann
Journal:  Dtsch Med Wochenschr       Date:  1983-04-15       Impact factor: 0.628

10.  [Clinical aspects and etiology of acrodermatitis chronica atrophicans].

Authors:  K Weber; G Schierz; B Wilske; V Preac-Mursic
Journal:  Hautarzt       Date:  1984-11       Impact factor: 0.751

View more
  43 in total

1.  Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease.

Authors:  V Preac Mursic; E Patsouris; B Wilske; S Reinhardt; B Gross; P Mehraein
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

2.  Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.

Authors:  Thomas B Ledue; Marilyn F Collins; John Young; Martin E Schriefer
Journal:  Clin Vaccine Immunol       Date:  2008-10-22

3.  Cross-reactive proteins of Borrelia burgdorferi.

Authors:  H R Bruckbauer; V Preac-Mursic; R Fuchs; B Wilske
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

4.  Spirochetes isolated from two patients with morphea.

Authors:  K Weber; V Preac-Mursic; C D Reimers
Journal:  Infection       Date:  1988       Impact factor: 3.553

5.  Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato.

Authors:  U Hauser; H Krahl; H Peters; V Fingerle; B Wilske
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

6.  Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi.

Authors:  V Preac-Mursic; B Wilske; G Schierz; E Süss; B Gross
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

7.  Serologic analyses of cottontail rabbits for antibodies to Borrelia burgdorferi.

Authors:  L A Magnarelli; J F Anderson; J B McAninch
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

8.  Persistent atrioventricular block in Lyme borreliosis.

Authors:  W Mayer; F X Kleber; B Wilske; V Preac-Mursic; W Maciejewski; H Sigl; E Holzer; W Doering
Journal:  Klin Wochenschr       Date:  1990-04-17

Review 9.  Treatment failure in erythema migrans--a review.

Authors:  K Weber
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

10.  Genotypic and phenotypic analysis of Borrelia burgdorferi isolates from The Netherlands.

Authors:  L M Nohlmans; R de Boer; A E van den Bogaard; C P van Boven
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.